D A Wohl
Overview
Explore the profile of D A Wohl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Golin C, Barkley B, Biddell C, Wohl D, Rosen D
AIDS Behav
. 2017 Apr;
22(6):1835-1848.
PMID: 28361452
Incarcerated populations have relatively high HIV prevalence but little has been reported about their aggregate HIV risk behaviors or perceptions of risk. A random selection of HIV-negative men (n = ...
2.
Wohl D, Bhatti L, Small C, Edelstein H, Zhao H, Margolis D, et al.
HIV Med
. 2015 Jul;
17(2):106-17.
PMID: 26176344
Objectives: HIV treatment guidelines endorse switching or simplification of antiretroviral therapy in therapy-experienced patients with suppressed viraemia; ritonavir discontinuation may also enhance tolerability and reduce long-term adverse events (AEs). This...
3.
Khan M, Golin C, Friedman S, Scheidell J, Adimora A, Judon-Monk S, et al.
AIDS Behav
. 2015 Apr;
19(8):1478-90.
PMID: 25863467
African Americans face disproportionate sexually transmitted infection including HIV (STI/HIV), with those passing through a correctional facility at heightened risk. There is a need to identify modifiable STI/HIV risk factors...
4.
Menezes P, Eron Jr J, Leone P, Adimora A, Wohl D, Miller W
HIV Med
. 2010 Sep;
12(3):183-91.
PMID: 20807254
Background: In the USA, women, racial/ethnic minorities and persons who acquire HIV infection through heterosexual intercourse represent an increasing proportion of HIV-infected persons, and yet are frequently underrepresented in clinical...
5.
Wohl D, Kendall M, Andersen J, Crumpacker C, Spector S, Feinberg J, et al.
HIV Clin Trials
. 2009 Jul;
10(3):143-52.
PMID: 19632953
Purpose: To describe cytomegalovirus (CMV) end-organ disease (EOD) rate in AIDS patients with low CD4+ cell count despite HAART who were enrolled in a randomized, placebo-controlled trial of preemptive valganciclovir...
6.
Wohl D, McComsey G, Tebas P, Brown T, Glesby M, Reeds D, et al.
Clin Infect Dis
. 2006 Aug;
43(5):645-53.
PMID: 16886161
Changes in fat distribution, dyslipidemia, disordered glucose metabolism, and lactic acidosis have emerged as significant challenges to the treatment of human immunodeficiency virus (HIV) infection. Over the past decade, numerous...
7.
Wohl D, Kendall M, Owens S, Holland G, Nokta M, Spector S, et al.
HIV Clin Trials
. 2005 Sep;
6(3):136-46.
PMID: 16192248
Background: Reconstitution of immune function during potent antiretroviral therapy can prompt discontinuation of maintenance cytomegalovirus (CMV) therapy but has also been associated with sight-threatening inflammatory conditions including immune recovery uveitis...
8.
Weinberg A, Wohl D, Barrett R, van der Horst C
J Infect Dis
. 2001 Aug;
184(6):707-12.
PMID: 11517431
Cytomegalovirus (CMV)-immune recovery was characterized in human immunodeficiency virus (HIV)-infected patients receiving highly active antiretroviral therapy. CMV lymphocyte proliferation (LP), responder-cell frequency (RCF), and interferon (IFN)-gamma and interleukin (IL)-2 secretion...
9.
Jacobson J, Greenspan J, Spritzler J, Fox L, Fahey J, Jackson J, et al.
J Infect Dis
. 2000 Dec;
183(2):343-346.
PMID: 11120935
A multicenter, double-blind, randomized, placebo-controlled study was conducted to determine the safety and efficacy of thalidomide in reduced, intermittent doses for preventing recurrences of oral and esophageal aphthous ulcers in...
10.
Weinberg A, Wohl D, Brown D, Pott G, Zhang L, Ray M, et al.
J Acquir Immune Defic Syndr
. 2000 Dec;
25(2):109-14.
PMID: 11103040
To determine the feasibility of cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) studies using cryopreserved cells, we compared lymphocyte proliferation assays (LPA), responder cell frequency (RCF), interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) production...